Bioindustry 4.0

www.bioindustry4.eu

Industrial Biotechnology (IB) is a Key Enabling Technology for the circular bio-economy, industrial renewal and European manufacturing autonomy. Its development forms a vital part of EU’s strategy to become climate neutral in 2050. For IB to become a major manufacturing technology, it must widen its use of advanced digital technologies. These will improve R&D efficiency, reducing time-to-market and costs. Moreover, for manufacturing, advanced digital
technologies will drive distributed, autonomous and highly adaptable production systems. To support digitalization of IB, BIOINDUSTRY 4.0 will create new services delivered by European research infrastructures (RI). These services will address several challenges, focusing on the acceleration of bio-process development pipelines. Drawing on the complementary skills of its consortium, BIOINDUSTRY 4.0 will develop data-driven approaches, exploiting AI to empower novel decision support systems and digital twins, the latter being to better design bio-processes and enable their real-time online control. To complete these services, BIOINDUSTRY 4.0 will also develop data and metadata standards to generate high quality, interoperable multi-scale bio-process data, the technical basis for trusted data networks and process analytical devices to provide real-time online monitoring of bio-processes. Once deployed, these RI services will provide Users with access to cutting-edge technologies that can be used singly or in an integrated way, covering whole R&D pipelines. Integrated services will be delivered by a distributed RI, conferring Europe with a unique R&D test-bed for bio-process development and a competitive advantage with respect to global competition.

  • Bioindustry 4.0 is a Horizon EU project launched in 2023 and scheduled to run for the next 4 years with funding of around 9,4 million Euros.
  • Bioindustry 4.0 brings together 6 EU RIs, 1 global company, 2 innovative EU SMEs and several research teams around an ambitious 4-year workplan that will be implemented in consultation with IB stakeholders, using a co-design strategy to specify goals.

Bioindustry 4.0 has received funding from the European Union’s Horizon research and innovation programme under grant agreement No 101094287.

PROJECT PARTNERS

  • INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE, L’ALIMENTATION ET L’ENVIRONNEMENT (INRAE)

  • ATHINA-EREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS, TON EPIKOINONION KAI TIS GNOSIS

  • SYMBIOLABS CIRCULAR INTELLIGENCE I.K.E.

  • BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE

  • CONSORTIUM (BBMRI-ERIC)

  • ASSOCIATION INDUSTRIES ET AGRORESSOURCES

  • CONSIGLIO NAZIONALE DELLE RICERCHE

  • LEIBNIZ-INSTITUT DSMZ-DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN GMBH

  • UNIVERSITAET KOBLENZ-LANDAU

  • INRAE TRANSFERT SAS

  • INSA TOULOUSE INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE

  • KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN – KNAW

  • LIFEGLIMMER GMBH

  • ETHNICON METSOVION POLYTECHNION

  • RWTH RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN

  • TIMEGATE INSTRUMENTS OY

  • UVEG UNIVERSITAT DE VALENCIA

  • VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.

  • TEKNOLOGIAN TUTKIMUSKESKUS (VTT)

  • WAGENINGEN UNIVERSITY

  • UNIVERSIDAD AUTONOMA DE BARCELONA

  • BIOFACTION KG

  • FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV

  • SIEMENS PROCESS SYSTEMS ENGINEERING LIMITED

  • THE UNIVERSITY OF MANCHESTER

  • UNIVERSITY OF NEWCASTLE UPON TYNE

BIOFACTION'S ROLE

Biofaction will facilitate the science-society interface for Bioindustry 4.0. We will contribute to the project by working on public engagement and communication. Biofaction will also engage with key stakeholders from industry, academiy and civil society to better understand the needs and challenges in developing infrastructures for the future of bioindustry.